Taiwan Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Taiwan Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Summary


GlobalData, the industry analysis specialist, has released its latest report, “Taiwan Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Taiwan. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Taiwan. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Taiwan’s healthcare system is emerging as one of the most advanced healthcare systems in Asia, with government policies supporting the biomedical industry and digital health trends developing Taiwan as regional hub for pharma R&D at the intersection of technology and medical science. Taiwan’s pharmaceutical market increased from $2.41B in 2011 to $2.66B in 2018, at a Compound Annual Growth Rate (CAGR) of 1.42%. Taiwan’s medical devices market was valued at $2.25B in 2015, which increased at a CAGR of 3.3% to reach $2.56B in 2019. The pharmaceutical market growth is attributed to a rapidly aging population, an increase in non-communicable diseases, and a rise in medical tourism. A new drug price control mechanism to contain spending on healthcare is expected to limit pharmaceutical growth.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Taiwan, and includes -

  • An overview of the pharmaceutical markets, comprising market size, segmentation, COVID-19 epidemiology and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Sinphar, China Chemical & Pharmaceutical Co, YungShin Global Holding Corp, TTY Biopharm Co, and Standard Chem & Pharm Co Ltd)
  • Profiles and SWOT analyses of the major players in the medical device market (Fresenius, Medtronic, Stryker, Baxter, and TaiDoc)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Taiwan
  • Information regarding the health-tech landscape of the country along with the major health-tech deals
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Taiwan healthcare market
Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Taiwan healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analysing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Taiwan healthcare market


1 Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlights: Facts About the Taiwan Healthcare Market
2.3 Key Highlights: Healthcare Start-Ups in Taiwan
2.4 Key Events: Taiwan Pharmaceutical Timeline, 2014-2020
2.5 Key Events: Taiwan Pharmaceutical Market
2.6 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Taiwan, 2019
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Pharmaceutical Expenditure
3.7 Pharmaceutical Market - COVID-19 Epidemiology
3.7.1 Pharmaceutical Market- Government Response to Mitigate COVID-19 Impact
3.7.2 Pharmaceutical Market- COVID-19 Impact and Developments in Healthcare Market
3.8 Pharmaceutical Market - Major Players
4 Overview of Medical Device Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Segments
4.2.1 Medical Devices Market - Hospital Supplies Devices
4.2.2 Medical Devices Market - Orthopedic Devices
4.2.3 Medical Devices Market - General Surgery Devices
4.2.4 Medical Devices Market - Ophthalmic Devices
4.2.5 Medical Devices Market - Nephrology and Urology Devices
4.3 Medical Devices Market - Diagnostics Market
4.4 Medical Devices Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal analysis
6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Taiwan, 2019-2020
6.2 Deal Analysis: M&A, VC, and PE Deals, Medical Devices Market, Taiwan, 2019-2020
7 HealthTech Landscape
8 Market Access
9 Country Healthcare Landscape
9.1 Healthcare Policy Highlights
9.2 Healthcare Facilities
9.3 Life Expectancy and Immunization Rate, Taiwan
9.4 Environmental Health
9.5 Healthcare Personnel
9.6 Disease Burden
9.7 Healthcare Expenditure
10 Trade Associations, Taiwan
11 Trade Fairs, Taiwan
12 Opportunities and Challenges
13 Appendix
List of Tables
Table 1: Role of Government Agencies Involved Against Counterfeit Medicines, Taiwan, 2019
Table 2: COVID-19 Indicators (Number of Cases), Global and Taiwan, 2020
Table 3: COVID-19 Clinical Trial, Taiwan, 2020
Table 4: COVID-19, In Vitro Diagnostics (IVD), COVID-19 Test Kit (Pipeline Products), Taiwan, 2020
Table 5: COVID-19, In Vitro Diagnostics Marketed Products, Taiwan, 2020
Table 6: Medical Devices Market, Major Segments by Revenue, Taiwan, 2019
Table 7: Hospital Supplies Devices Market, Taiwan, Revenue ($M) and Market Share (%) of Major Companies, 2016
Table 8: Orthopaedic Devices Market, Taiwan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 9: General Surgery Devices Market, Taiwan, Revenue ($M) and Market Share (%) of Major Companies, 2016
Table 10: Ophthalmic Devices Market, Taiwan, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 11: Nephrology and Urology Devices Market, Taiwan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 12: Premium Contribution Ratios under NHI System, 2018
Table 13: Basic Outpatient Care Co-payments ($), 2019
Table 14: Coinsurance for Inpatient Care, Taiwan, 2019
Table 15: Registration Fee Structure for New Drug Application ($), 2019
Table 16: Regulatory Requirement for Medical Devices, 2019
Table 17: Medical Equipment Classification, Taiwan, 2019
Table 18: Patent, Schedule of Patent Fees, Taiwan, 2019
Table 19: Schedule of Trademark Fees, Taiwan, 2019
Table 20: Outcomes of New Amendments for Clinical Trail, Taiwan, 2019
Table 21: Trade Fairs, Taiwan
List of Figures
Figure 1: Pharmaceutical Market, Taiwan, Revenue ($B), 2011-2019
Figure 2: Medical Devices Market, Taiwan, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Taiwan, Taiwan, 2019
Figure 4: Country Profile, Taiwan, 2019
Figure 5: Pharmaceutical Market, Taiwan, Revenue ($B), 2011-2018
Figure 6: Pharmaceutical Market, Taiwan, Revenue Forecast ($B), 2019-2025
Figure 7: Pharmaceutical Exports ($B), Taiwan, 2012-2019
Figure 8: Top Export Partners, Taiwan, 2019
Figure 9: Pharmaceutical Imports ($B), Taiwan, 2012-2019
Figure 10: Top Import Partners, Taiwan, 2019
Figure 11: Framework of the Cross-Departmental Task Force on Counterfeit Medicines in Taiwan, 2019
Figure 12: Major Generic Drug Companies, Taiwan, 2019
Figure 13: Pharmaceutical and OTC Regulatory Timeline, Taiwan, 2017
Figure 14: OTC Market, Taiwan, Revenue ($M), 2011-2020
Figure 15: Expenditure on Pharmaceuticals (% of Current Health Expenditure), Taiwan, 2010-2018
Figure 16: Expenditure on Pharmaceuticals (% of GDP), Taiwan, 2010-2018
Figure 17: Pharmaceutical Market, COVID-19 (Number of cases), Taiwan, 2020
Figure 18: Pharmaceutical Market, COVID-19 (Number of deaths), Taiwan, 2020
Figure 19: Medical Devices Market, Taiwan, Revenue Forecast ($B), 2015-2020
Figure 20: Medical Devices Market, Taiwan, Revenue Forecast ($B), 2021-2025
Figure 21: Medical Devices Market, Major Segments (%), Taiwan, 2019
Figure 22: Hospital Supplies Market, Taiwan, Revenue ($M), 2015-2022
Figure 23: Hospital Supplies Market, Taiwan, Market Share of Major Players (%), 2016
Figure 24: Orthopaedic Devices Market, Taiwan, Revenue ($M), 2015-2022
Figure 25: Orthopaedic Devices Market, Taiwan, Market Share of Major Players (%), 2019
Figure 26: General Surgery Devices Market, Taiwan, Revenue ($M), 2015-2022
Figure 27: General Surgery Devices Market, Taiwan, Market Share of Major Players (%), 2016
Figure 28: Ophthalmic Devices Market, Taiwan, Revenue ($M), 2015-2022
Figure 29: Ophthalmic Devices Market, Taiwan, Market Share of Major Players (%), 2015
Figure 30: Nephrology and Urology Devices Market, Taiwan, Revenue ($M), 2015-2022
Figure 31: Nephrology and Urology Devices Market, Taiwan, Market Share of Major Players (%), 2015
Figure 32: Diagnostic Market, Taiwan, Revenue ($M), 2015-2020
Figure 33: Diagnostic Market, Taiwan, Revenue ($M), 2021-2025
Figure 34: Medical Devices Market, Taiwan, Revenue ($B) of Major Companies, 2017
Figure 35: Deal Value and Deal Count, Pharmaceutical Market, Taiwan, 2019-2020
Figure 36: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Taiwan, 2019-2020
Figure 37: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Taiwan, 2019-2020
Figure 38: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Taiwan, 2019-2020
Figure 39: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Taiwan, 2019-2020
Figure 40: M&A Deals by Therapy Area, Pharmaceutical Market, Taiwan,2019-2020 (by value and by number)
Figure 41: Venture Capital Deals by Therapy Area, Pharmaceutical Market,Taiwan, 2019-2020 (by value and by number)
Figure 42: Deal Value and Deal Count, Medical Devices, Taiwan, 2019-2020
Figure 43: Deal Value and Deal Count Quarterly, Medical Devices, Taiwan, 2019-2020
Figure 44: Deal Value and Deal Count Sub-Types, Medical Devices, Taiwan, 2019-2020
Figure 45: Top Five Therapy Areas by Deal Value, Medical Devices, Taiwan, 2019-2020
Figure 46: Top Five Therapy Areas by Deal Number, Medical Devices, Taiwan, 2019-2020
Figure 47: Venture Capital Deals by Therapy Area, Medical Devices, Taiwan, 2019-2020 (by value and by number)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook